Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells

European Journal of Immunology

Volumn 28, Issue 9, 1998, Pages 2714-2725

  Martínez Lorenzo, María José ^a   Alava, Maria A ^a   Gamen, Susana ^a   Jin Kim, K ^b   Chuntharapai, Anan ^b   Piñeiro, Andrés ^a   Naval, Javier ^a   Anel, Alberto ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b GENENTECH INC   (United States)

Author keywords

Activation induced cell death; APO2 ligand; Fas; Fas ligand; T lymphocyte; TRAIL

Indexed keywords

FAS ANTIGEN; FAS LIGAND; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ;

ARTICLE; CELL DEATH; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LEUKEMIA CELL LINE; MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; FAS LIGAND PROTEIN; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031719383     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199809)28:09<2714::AID-IMMU2714>3.0.CO;2-9     Document Type: Article

References (52)

1. Ashwell, J. D., Longo, D. L. and Bridges, S. H., T-cell tumor elimination as a result of T-cell receptor-mediated activation. Science 1987. 237: 61-64.
2. Jones, L. A., Chin, L. T., Longo, D. L. and Kruisbeek, A. M., Peripheral clonal elimination of functional T cells. Science 1990. 250: 1726-1729.
3. Webb, S., Morris, C. and Sprent, J., Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 1990. 63: 1249-1258.
4. Russell, J. H., White, C. L., Loh, D. Y. and Meleedy-Rey, P., Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc. Natl. Acad. Sci. USA 1991. 88: 2151-2153.
5. Russell, J. H., Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 1995. 7: 382-388.
6. Abbas, A. K., Die and let live: eliminating dangerous lymphocytes. Cell 1996. 84: 655-657.
7. Russell, J. H., Rush, B., Weaver, C. and Wang, R., Mature T cells of autoimmune Ipr/Ipr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 1993. 90: 4409-4413.
8. Russell, J. H. and Wang, R., Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur. J. Immunol. 1993. 23: 2379-2382.
9. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S., Lymphoproliferation disorder explained by defects in Fas antigen that mediate apoptosis. Nature 1992. 356: 314-318.
10. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994. 76: 969-978.
11. Vignaux, F. and Golstein, P., Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 1994. 24: 923-928.
12. Krammer, P. H., Dhein, J., Walczak, H., Behman, I., Mariani, S., Matiba, B., Path, M., Daniel, P. T., Knipping, E., Westendorp, M. O., Stricker, K., Bäumler, C., Hellbardt, S., Germer, M., Peter, M. E. and Debatin, K. M., The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 1994. 142: 175-185.
13. Nagata, S. and Golstein, P., The Fas death factor. Science 1995. 267: 1449-1456.
14. Dhein, J., Walczak, H., Bäumler, C., Debatin, K. M. and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 1995. 373: 438-441.
15. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F. and Green, D. R., Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995. 373: 441-444.
16. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak-Rothstein, A., Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995. 373: 444-448.
17. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F. and Lynch, D. H., Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995. 181: 71-77.
18. Singer, G. G. and Abbas, A. K., The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994. 1: 365-371.
19. Lynch, D. H., Ramsdell, F. and Alderson, M. R., Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 1995. 16: 569-574.
20. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 1995. 377: 348-351.
21. Sytwu, H. K., Liblau, R. S. and McDevitt, H. O., The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996. 5: 17-30.
22. + T cells. Int. Immunol. 1996. 8: 675-681.
23. + T cells after antigen challenge in the absence of Fas (CD95). Eur. J. Immunol. 1996. 26: 2903-2910.
24. Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A. and Ashkenazi, A., Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 1996. 271: 12687-12690.
25. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A. and Goodwin, R. G., Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995. 3: 673-682.
26. Chinnaiyan, A. M., O'Rourke, K., Yu, G. L., Lyons, R. H., Garg, M., Duan, D. R., Xing, L., Gentz, R., Ni, J. and Dixit, V. M., Signal transduction by DR3, a death domain-containing receptor related to TNFR1 and CD95. Science 1996. 274: 990-992.
27. Marsters, S. A., Sheridan, J. P., Donahue, C. J., Pitti, R. M., Gray, C. L., Goddard, A. D., Bauer, K. D. and Ashkenazi, A., Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-אB. Curr. Biol. 1996. 6: 1669-1676.
28. Kitson, J., Raven, T., Jiang, Y. P., Goeddel, D. V., Giles, K. M., Pun, K. T., Grinham, C. J., Brown, R. and Farrow, S. N., A death domain-containing receptor that mediates apoptosis. Nature 1996. 384: 372-375.
29. Bodmer, J. L., Burns, K., Schneider, P., Hofmann, K., Steiner, V., Thome, M., Bornand, T., Hahne, M., Schröter, M., Becker, K., Wilson, A., French, L. E., Browning, J. L., MacDonald, H. R. and Tschopp, J., TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 1997. 6: 79-88.
30. Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J. and Dixit, V. M., The receptor for the cytotoxic ligand TRAIL. Science 1997. 276: 111-113.
31. Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., Goddard, A. D., Godowski, P. and Ashkenazi, A., Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997. 277: 818-821.
32. Pan, G., Ni, J., Wei, Y. F., Yu, G. L., Gentz, R. and Dixit, V. M., An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997. 277: 815-818.
33. Marsters, S. A., Pitti, R. M., Donahue, C. J., Ruppert, S., Bauer, K. D. and Ashkenazi, A., Activation of apoptosis by APO2 ligand is independent of FADD but blocked by CrmA. Curr. Biol. 1996. 6: 750-752.
34. + T cells. Eur. J. Immunol. 1996. 26: 2263-2270.
35. Martínez-Lorenzo, M. J., Alava, M. A., Anel, A., Piñeiro, A. and Naval, J., Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells. Immunology 1996. 89: 511-517.
36. Martínez-Lorenzo, M. J., Gamen, S., Etxeberria, J., Lasierra, P., Larrad, L., Piñeiro, A., Anel, A., Naval, J. and Alava, M. A., Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemias. Int. J. Cancer 1998. 75: 473-481.
37. Slee, E. A., Zhu, H., Chow, S. C., MacFarlane, M., Nicholson, D. W. and Cohen, G. M., Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 1996. 315: 21-24.
38. Mariani, S. M., Matiba, B., Armandola, E. A. and Krammer, P. H., lnterleukin 1β-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J. Cell. Biol. 1997. 137: 221-229.
39. Stokes, T. A. et al., Constitutive expression of FasL in thyrocytes. Science 1998. 279: 2015.
40. Gamen, S., Marzo, I., Anel, A., Piñeiro, A. and Naval, J., CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells. FEBS Lett. 1996. 390: 233-237.
41. Henderson, D. J., Elliot, D. G., Smith, G. M., Webb, T. E. and Dainty, I. A., Cloning characterisation of a bovine P2Y receptor. Biochem. Biophys. Res. Commun. 1995. 212: 648-656.
42. Anel, A., Naval, J., González, B., Torres, J. M., Mishal, Z., Uriel, J. and Piñeiro, A., Fatty acid metabolism in human lymphocytes. I. Time-course changes in fatty acid composition and membrane fluidity during blastic transformation of peripheral blood lymphocytes. Biochim. Biophys. Acta 1990. 1044: 323-331.
43. Kiener, P. A., Davis, P. M., Rankin, B. M., Klebanoff, S. J., Ledbetter, J. A., Starling, G. C. and Liles, W. C., Human monocytic cells contain high levels of intracellular Fas ligand. Rapid release following cellular activation. J. Immunol. 1997. 159: 1594-1598.
44. Parr, E. J., Myles, E. B., Hanani, M., Seror, D., Riabowol, K. T. and Sharkey, K. A., Immunoreactivity for the Fas ligand in the mammalian enteric nervous system. Cell Tissue Res. 1997. 290: 21-29.
45. Thornberry, N. A., Bull, H. G., Calaycay, J. R. et al., A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992. 356: 768-774.
46. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T. T., Yu, V. L. and Miller, D. K., Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995. 376: 37-43.
47. Pronk, G. J., Ramer, K., Amiri, P. and Williams, L. T., Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 1996. 271: 808-810.
48. Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D., Abbot, B. J., Mayo, J. G., Schoemaker, R. H. and Boyd, M. R., Sensibility of drug screening with panels of human tumor cell lines using microculture tetrazolium assay. Cancer Res. 1988. 46: 589-601.
49. Anel, A., Naval, J., Desportes, P., González, B., Uriel, J. and Piñeiro, A., Increased cytotoxicity of polyunsaturated fatty acids on human tumoral B and T-cell lines compared with normal lymphocytes. Leukemia 1992. 6: 680.
50. Martin, S. J., Reutelingsperger, C. P. M., McGahon, A. J., Rader, J. A. van Schie, R. C. A. A., LaFace, D. M. and Green, D. R., Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 1995. 182: 1545-1556.
51. Anel, A., Gamen, S., Alava, M. A., Schmitt-Verhulst, A. M., Pineiro, A. and Naval, J., Role of oxidative damage and ICE-like proteases in Fas-based cytotoxicity exerted by effector T cells. Int. Immunol. 1996. 8: 1173-1183.
52. Alava, M. A., DeBell, K. E., Conti, A., Hoffman, T. and Bonvini, E., Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation. Association with protein kinase A phosphorylation of phospholipase C-γ1. Biochem. J. 1992. 284: 189-199.